Why we fight the battle against childhood cancer

Texas is poised to be a world leader in childhood cancer research.
Children are not little adults and childhood cancers are very different from adult cancers. Improved treatments are needed as approximately 20% of childhood cancers are unresponsive to current treatments and most cures are often associated with significant lifelong consequences. It is because of this that CPRIT makes research specific to childhood cancers a priority.

$280 million

12% of CPRIT’s portfolio goes to childhood cancer projects–proportionally 3 times the national rate.

$42 million

CPRIT provided funding for childhood brain cancer research, spanning bench, translational and product development research.

$506 million

Additional follow-on funding for childhood cancer research from other agencies obtained by grantees leveraging CPRIT awards.

Making a Difference

Tackling the biggest challenges in childhood cancer research

CPRIT is helping the state’s most prominent cancer research institutions address two of the biggest challenges in childhood cancer research and treatment: making current treatments more effective and with fewer negative side effects.

With CPRIT’s assistance the institutions providing childhood cancer care in Texas have developed into national power houses for treatment and give us great hope as we go forward.

Featured Project

A Texas-based company developing a new drug targeting Ewing sarcoma

We wouldn’t be here today without the Cancer Prevention & Research Institute of Texas

David Arthur, Salarius Pharmaceutical CEO

Recipient of a 3-year $18.7 million CPRIT Product Development award

Rang the Nasdaq stock market opening bell July 30, 2019

We wouldn’t be here today without the Cancer Prevention & Research Institute of Texas

David Arthur, Salarius Pharmaceutical CEO

Recipient of a 3-year $18.7 million CPRIT Product Development award

Rang the Nasdaq stock market opening bell July 30, 2019

CPRIT Scholars

Recruiting world-class scientists–many of whom are focused on childhood cancer research–to Texas universities and cancer research institutes

Learn more about other CPRIT Scholars at scholars.cprit.texas.gov

Dr. Elizabeth Maher, Professor of Internal Medicine and Neurology & Neurotherapeutics at UT Southwestern, and Carson Leslie Foundation founder Annette Leslie, discuss how CPRIT grants are impacting childhood cancer research in Texas.
  • 1,700 children younger than 20 are diagnosed with cancer every year in Texas
  • 200 children die of cancer each year–the most common disease-related killer of Texans under 20
  • 7,200 adolescents and young adults are diagnosed with cancer each year in Texas

CPRIT Core Facilities in Childhood Cancer

Texas Pediatric Patient Derived Xenograft Facility Received $5,079,843 in Funding
Developing models to test new therapies that represent the genetic diversity of childhood cancer of all Texas children.
Learn More
What is CPRIT's Advisory Committee on Childhood Cancers (ACCC)?
The Advisory Committee on Childhood Cancers (ACCC) collects relevant information and advises the Oversight Committee on issues surrounding childhood cancer.


Learn More
$25 million in HPV-related cancer prevention grants
CPRIT is preventing cancer-causing infections and precancers by funding HPV vaccination projects throughout Texas.
Copyright © 2019 Cancer Prevention & Research Institute of Texas